^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ABP 494 (cetuximab biosimilar)

    i
    Other names: ABP 494

    Associations

    News
    Trials
    Company:
    AbbVie, Amgen
    Drug class:
    EGFR inhibitor
    Related drugs:

    Associations

    News
    Trials